Skip to content

Faculty profile

Philip Halloran

Back to faculty
ProfessorMedicine DeptUniversity of Alberta

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

  • The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection.

    Kidney international reports · 2025

  • The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024

  • Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies

    Journal of the American Society of Nephrology · 2020

All 8 publications

Latest funding

  • Pharmacogenetic translational biomarker discovery

    CFI · 2013 · Co-investigator

    $277,985
  • Interferon-gamma and interferon-gamma-dependent MHC class I expression dictates the local inflammatory reaction.

    CIHR · 2009 · Supervisor

    $17,500
  • Creation of the Alberta Transplant Applied Genomics Centre (ATAGC)

    CFI · 2006 · Principal investigator

    $5,064,408
All 5 grants and awards

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction